Previously published studies reported variable results using various suture techniques and reconstruction options for massive rotator cuff tears. Therefore, the current authors retrospectively studied 21 consecutive patients/shoulders with massive rotator cuff tears treated from January 2005 to October 2011 with a human dermal allograft through a mini-open approach. Mean patient age was 58 years (range, 33-72 years). Mean follow-up was 29 months (range, 18-52 months). Ten patients underwent revision repair for a failed rotator cuff repair. The authors measured the tendon gap (mean, 1.7 cm) and acromiohumeral interval (mean, 6.5 mm). They evaluated pain, shoulder range of motion (ROM) and function, patient satisfaction with the operation and outcome, and complications. At last follow-up, all patients experienced significant pain relief (P=.001) and improved ROM (P=.001) and American Shoulder and Elbow Surgeons (ASES) score (P=.001). Eighteen patients reported that they were satisfied or very satisfied and 3 reported that they were not satisfied with the operation and outcome. Comparison of outcomes between patients who underwent primary repair and those who underwent revision repair and between patients who had muscle atrophy and fatty infiltration grades 0 to II and those who had grades III to IV showed no statistically significant differences. A statistically significant correlation was observed between the size of the tendon gap and postoperative pain, ROM (except external rotation), and ASES score (P<.050). No significant correlation was observed between postoperative pain, ROM, and ASES score and the acromiohumeral interval (P>.050). Complications related to the dermal human allograft were not observed. [Orthopedics. 2014; 37(12) :e1108-e1116.] M assive rotator cuff tears are tears greater than 5 cm and involve at least both the supraspinatus and infraspinatus components of the rotator cuff. These tears may be traumatic or degenerative. In elderly patients with glenohumeral arthritis, reverse shoulder arthroplasty is usually an option. However, younger patients with a traumatic rupture or patients of any age with an increased demand of manual activity need a more functional shoulder, free of pain with a good range of motion (ROM). [1] [2] [3] [4] [5] The biomechanical rationale for repair of massive rotator tears has been previously studied. 3, 6 Available reconstruction options include open and arthroscopic procedures.
1,2,7-11 Suture repair under tension has been associated with a high rate of failure of the repair. [1] [2] [3] [4] [5] In this setting, Boehm et al 10 reported that the weakness of the repair was at the tendon-suture interface, the thread, and the suture-to-bone interface; in confirmed reruptures after rotator cuff reconstructions, the use of nonabsorbable sutures has shown a poorer outcome compared with that with absorbable sutures. 10 To reduce failure rates, tendon transfers (eg, biceps, subscapularis, teres minor, latissimus dorsi, and pectoralis major) and autografts (eg, fascia lata) have been described. [12] [13] [14] In addition, biological augmentation techniques using synthetic grafts such as polylactic acid, polytetrafluoroethylene (Gore-Tex; WL Gore and Associates, Newark, Delaware), and polyester ethylene terephthalate (Dacron; Xiros, Leeds, United Kingdom); porcine (Restore; DePuy Orthopedics, West Chester, Pennsylvania; CuffPatch; Arthrotek, Warsaw, Indiana; ZCR Patch; Zimmer, Warsaw, Indiana), bovine (TissueMend; Stryker, Mahwah, New Jersey; BioBlanket; Kensey Nash Corp, Exton, Pennsylvania), and equine (OrthADAPT; Pegasus Biologic Inc, Irvine, California) xenografts; and human dermal or human acellular dermis allografts (GraftJacket; Wright Medical Technology Inc, Arlington, Tennessee) have been reported. 4, 6, [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] However, the optimal suture technique and synthetic graft for massive rotator cuff tears remain unclear. Previous studies reported variable results using various synthetic grafts and suture techniques. Mura et al 4 suggested that a synthetic graft can redirect the forces to the glenohumeral joint, whereas Zumstein et al 5 used a transosseous technique and synthetic graft repair and reported a rerupture rate of 37% at 3 years and 57% at 9 years. A disadvantage of synthetic grafts is the possibility of a foreign-body reaction to synthetics and tissue reaction. [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] Xenografts have been associated with higher failure rates, which have been related to tissue origin species and sterilization methods. [19] [20] [21] [22] [23] [24] [25] To enhance the literature, the current authors performed this study to present a series of patients with massive rotator cuff tears treated with human dermal allograft through a mini-open repair technique.
Materials and Methods
The authors retrospectively studied 21 consecutive patients (21 shoulders) with massive rotator cuff tears treated at the authors' institutions from January 2005 to October 2011 with a human dermal allograft (GraftJacket) through a mini-open approach. There were 15 men and 6 women with a mean age of 58 years (range, 33-72 years) ( Table 1) . Surgery was performed on 15 right and 6 left shoulders; 16 shoulders involved the dominant side. Ten of the 21 patients underwent revision repair for a failed rotator cuff repair; these patients had a total of 22 arthroscopic or open shoulder operations prior to the human dermal allograft procedure. Five of the 11 patients who had a primary repair with human dermal allograft had a traumatic tear, and 6 had gradual onset of pain due to degenerative rotator cuff disease. Minimum follow-up was 18 months (mean, 29 months; range, 18-52 months); no patient was lost to follow-up. All patients gave written informed consent for their data to be included in this retrospective study. This study was approved by the institutional review boards/ethics committees of the authors' institutions.
During the study period, a total of 31 consecutive patients (31 shoulders) with massive rotator cuff tears were treated at the authors' institutions with a human dermal allograft through the same approach. Ten of these patients were added late to the cohort and had a mean follow-up of 9 months (range, 6-12 months). At the time of this writing, these patients still experience mild symptoms, including shoulder pain or soreness, after their rotator cuff surgery. Because the authors believe that more than 1 year is needed for the tendon to be completely healed to the bone and shoulder strength to be completely restored, [26] [27] [28] these patients were not included in the analysis.
Preoperatively, all patients had standard radiographs obtained of the affected shoulder, including anteroposterior, axillary, and scapular outlet views; no patient had radiographic evidence of glenohumeral arthritis, 19 patients had acromioclavicular joint arthritis, and 2 patients had a previous distal clavicle resection. Nine patients had a type II acromion, 6 patients had a type III acromion, and 6 patients had a previous acromioplasty for a type II (n=2) or type III (n=4) acromion. 29 The acromiohumeral interval was measured on the anteroposterior view of the shoulder with the arm at the side in neutral rotation. Mean acromiohumeral interval of the patients in this series was 6.5 mm (range, 3.5-10.2 mm); a value less than 6 mm is considered indicative of rotator cuff tear. [30] [31] [32] [33] Magnetic resonance imaging (MRI) of the affected shoulder was performed using TI-and T2-weighted sequences in axial, coronal, and oblique-sagittal planes. Magnetic resonance imaging was available for all but one patient who had a cardiac pacemaker. A severely retracted supraspinatus and infraspinatus tendon at the level of the glenoid was identified in the coronal views in all patients. This finding was considered as a strong in-dication for the use of an interpositional allograft for rotator cuff reconstruction, particularly in the revision surgeries, although the final decision was made intraoperatively. The subscapularis tendon was intact in all cases. The authors evaluated rotator cuff atrophy and fatty infiltration in spin-echo T1-weighted MRIs on an oblique-sagittal plane (Y-shaped view) as described by Thomazeau et al. 34 The authors graded rotator cuff atrophy and fatty infiltration according to the Goutallier et al 35 classification (grades 0-IV). Evaluation was done by radiologists and surgeons (Z.T.K., A.F.M., D.G.S.) with no disagreement in the diagnosis or classification of any patient.
Magnetic resonance imaging evaluation for rotator cuff atrophy revealed 8 patients with no evidence of muscle atrophy and 12 patients with various grades of fatty infiltration and muscle atrophy ( Tables  1-2) . 35 All surgeries were performed with the patients in n Feature Article a 70° beach-chair position under general anesthesia. Initially, diagnostic arthroscopy was performed to assess the glenohumeral joint; biceps tendon; and size, configuration, and location of the rotator cuff tear. At arthroscopy, rotator cuff tears were considered massive if they were larger than 5 cm and both the supraspinatus and infraspinatus tendons were torn. The subscapularis tendon was intact in all patients, whereas the long head of the biceps showed degenerative changes in 15 patients. A moderate to severe fraying was observed in 10 patients and a partial rupture of the long head of the biceps was observed in 5 patients; in these patients, long head of the biceps tenotomy and tenodesis were performed. Chondral lesions of the glenohumeral joint were observed in all patients. Next, the mobility of the massive rotator cuff tear was evaluated with an arthroscopic probe; if more than 5-cm retraction of the rotator cuff was observed, the rotator cuff could not be mobilized to the anatomical insertion and a tension-free repair could not be obtained with less than 60° of Table 2 Pre-and Postoperative ROM and ASES Scores shoulder abduction, open cuff repair with allograft interposition was performed.
Open repair was performed through an anterior incision centered at the anterolateral corner of the acromion. The deltoid muscle was detached from the anterior aspect of the acromion and split in line with its fibers to obtain access to the rotator cuff. Then, a primary acromioplasty was performed in 11 patients, as previously described, 36 and distal clavicle resection was performed in 13 patients with advanced acromioclavicular joint arthritis. Next, the edges of the rotator cuff tears were identified and debrided, and the bone insertion site of the tendon was lightly abrased to create a bleeding surface. Mobilization of the rotator cuff was done with capsular release. By applying continuous traction to the rotator cuff, the distance between the retracted tear and anatomical insertion was measured. This was defined as the tendon gap, which had to be bridged with the human dermal allograft. Mean tendon gap of the patients in this series was 1.7 cm (range, 1-2.5 cm); mean tendon gap was significantly higher in the group of patients who had revision rotator cuff repair (2.05 cm) vs those who had primary rotator cuff repair (1.36 cm; P=.009). Then, the human dermal allograft was interpositioned at the tendon gap to cover the entire defect on the humeral head. The allograft was sutured anteriorly, posteriorly, and medially to the remaining cuff with nonabsorbable sutures (FiberWire; Arthrex Inc, Naples, Florida). Laterally, the allograft was secured to bone with 5.5-mm suture anchors (Bio-Corkscrew FT; Arthrex Inc) loaded with two No. 2 nonabsorbable sutures (FiberWire). The number of suture anchors used to reattach the tendon to bone was based on the size and configuration of the tear (mean, 3 anchors; range, 2-5 anchors).
Postoperatively, all patients followed a standard rehabilitation protocol. The arm was maintained in a sling with 30° abduction and internal rotation for 6 weeks for protection of the repair. The sutures were removed at 2 weeks. Passive ROM began at 4 to 6 weeks and active ROM began at 6 to 8 weeks. Muscle-strengthening exercises were instructed at 10 to 12 weeks.
Routine follow-up evaluation was performed at 6 weeks; 3, 6, and 12 months; and then every 6 months postoperatively. Follow-up evaluation included evaluation of pain, shoulder ROM and function, and patient satisfaction with the operation and outcome. Pain was measured on a visual pain scale from 0 (no pain) to 10 (severe and constant pain). 37 Shoulder ROM (forward flexion, external rotation, and abduction) was measured with a goniometer. Function was evaluated using the shoulder score of the American Shoulder and Elbow Surgeons (ASES). 38 Patient satisfaction with the operation and outcome was graded as very satisfied, satisfied, or not satisfied. Comparison in terms of outcome (pain relief, forward flexion, abduction, external rotation, and ASES score) was done with respect to rotator cuff repair (patients with primary vs those with revision repair) and muscle atrophy and fatty infiltration (patients with grades 0 to II vs those with grades III to IV). Complications were recorded. Preoperative (at baseline) and postoperative (at last follow-up) ROM and shoulder scores were compared with the Wilcoxon signed rank test. Comparison in terms of outcome between patients who had primary rotator cuff repair vs revision rotator cuff repair and between patients who had muscle atrophy and fatty infiltration grades 0 to II vs grades III to IV was done with the Mann-Whitney U test. The statistical association between variables was evaluated with Spearman's rank correlation coefficient. All reported P values were 2-tailed, with a value less than .050 considered statistically significant. The data were analyzed using MedCalc version 11.1 statistical software (MedCalc, Mariakerke, Belgium).
results
At a mean follow-up of 29 months (range, 18-52 months), all patients experienced significant pain relief and improvement of ROM and ASES score ( Table  2) . Mean pain score improved from 7.6 points (range, 4-9 points) preoperatively to 1.8 points (range, 0-5 points) postoperatively (P=.001). Mean forward flexion improved from 77° preoperatively to 139° postoperatively (P=.001); mean abduction improved from 67° preoperatively to 126° postoperatively (P=.001); and mean external rotation increased from 9° preoperatively to 47° postoperatively (P=.001). Mean ASES score improved from 25.2 points (range, 15-34 points) preoperatively to 74.3 points (range, 52-94 points) postoperatively (P=.001) ( Table 3) . Eighteen (86%) patients reported being very satisfied (Figure 1 ) or satisfied ( Figure  2 ) with the operation and outcome, and 3 (14%) patients reported not being satisfied with the operation and outcome ( Tables  1-2 ). The authors cannot explain why the 3 patients were not satisfied; they observed no differences between these patients and those who were satisfied. All patients had similar tissue quality (muscle atrophy and fatty infiltration) and glenohumeral chondral lesions, and intraoperative difficulty of the repair was not encountered.
Comparison in terms of outcome between the patients who had primary vs revision rotator cuff repair showed no statistically significant difference with respect to pain relief (P=.620), forward flexion (P=.600), abduction (P=.600), external rotation (P=.620), and ASES score (P=.100). Comparison in terms of outcome between the patients who had muscle atrophy and fatty infiltration grades 0 to II vs those who had grades III to IV showed no statistically significant difference with respect to pain relief (P=.600), forward flexion (P=.600), abduction (P=.600), external rotation (P=.630), and ASES score (P=.150).
A statistically significant correlation was observed between the size of the tendon gap and postoperative pain, ROM (except external rotation), and ASES score ( Table 4) . No significant correlation was observed between the acromiohumeral interval and postoperative pain, ROM, and ASES score (r s =-0.410; P=.0650). Recurrence of clinical symptoms, foreign body reactions, or other complications related to the dermal human allograft were not observed during the study period.
discussion
Management of massive rotator cuff tears is challenging. The reported reconstruction options for rotator cuff tears have been associated with conflicting results [1] [2] [3] [4] [5] 10 ; the tendon-suture and sutureto-bone interface have been reported to be the weakest areas, leading to repair failure. 10 Currently, tissue-engineered biomaterials are available as an alternative reconstructive procedure to augment rotator cuff repairs. However, the outcome ; the optimal suture technique and synthetic graft for massive rotator cuff tears remains unclear. This article presents a series of patients with massive rotator cuff tears treated with a human dermal allograft through a mini-open approach. At last follow-up, all patients experienced significant pain relief and improvement of ROM and ASES score, with no difference between patients who had primary vs revision rotator cuff repair. The size of the tendon gap was the only important predictor of postoperative pain, ROM (except external rotation), and ASES score. Most patients reported being satisfied or very satisfied with the operation. Reruptures and complications were not observed in any patient during the study period.
This study has limitations. First, the study design is retrospective. The authors acknowledge this limitation; however, the authors believe that well-controlled retrospective studies are useful to draw conclusions for a treatment approach. A retrospective study is a medical research study in which the medical records of groups of individuals who are alike in many ways but differ by a certain characteristic are compared for a particular outcome. Compared with prospective studies, the disadvantages of retrospective studies include errors due to confounding variables, selection bias, and misclassification or information bias. With retrospective studies, the temporal relationship is frequently difficult to assess. Furthermore, those conducting retrospective studies cannot control exposure or outcome assessment, but instead need to rely on others for accurate record keeping. Retrospective studies can need large sample sizes for rare outcomes. In contrast, the advantages of retrospective studies are that they are conducted on a smaller scale, they typically require less time to complete, they are better for analysis of multiple outcomes, they can potentially address rare diseases (which would necessitate extremely large cohorts in prospective studies), they are less expensive because outcomes and exposures have already occurred, and resources are mainly directed at data collection only. 39 A second limitation of the study is that it lacks a control group. A randomized controlled trial is the most powerful tool in research. The key distinguishing feature of a randomized, controlled trial is that the study participants, after assessment of eligibility and recruitment but before the study intervention begins, are randomly allocated to receive one of the treatments under study. The most important advantage of proper randomization is that it minimizes allocation bias, balancing both known and unknown prognostic factors, in the assignment of treatments. A disadvantage is that random allocation in real trials may be complex. 39 The authors acknowledge this limitation; however, currently, the optimal synthetic graft for massive rotator cuff tears remains unclear.
In addition, the variation of surgical techniques, surgeons' preferences, and cost precludes the authors from performing a randomized controlled study at present. In the future, the authors hope to conduct a randomized trial to compare human dermal allograft with a novel implant for patients with massive rotator cuff tears.
A third limitation of the study is that no structural evaluation of the rotator cuff repair was documented with either ultrasonography or MRI. It is well documented that rotator cuff rerupture after repair ranges from 2% to 50% or even higher in massive tears. 2, 3, 5, 8, 10 Many of these patients may not have significant symptoms. The authors acknowledge this limitation; however, although routine follow-up of the patients was performed, the authors do not routinely perform ultrasonography or MRI in their patients, except if significant symptoms persist or recur or if there is evidence of complications, which was not the case in any patient in the current series. Moreover, all data in this retrospective series were obtained from the patients' charts and medical files; no patients were specifically recalled for the purpose of this study.
A fourth limitation is that the exclusion of 10 patients who did not make it to 18-month follow-up may represent a potential introduction of selection bias to the data. However, to draw useful conclusions, the authors arbitrarily included only patients with a minimum 18-month follow-up because they agree with previous reports that more than 1 year is needed before the shoulder feels completely normal and strength in the shoulder muscles is fully recovered after rotator cuff surgery. 27 It is normal to expect continued symptoms of shoulder pain or soreness for several months postoperatively; it takes the repaired rotator cuff tendons approximately 8 weeks to heal initially to the bone, 4 months to form a relatively strong attachment to the bone, and 9 months before the tendon is completely healed to the bone. [26] [27] [28] The 10 patients excluded from the current study had a mean follow-up of 9 months (range, 6-12 months); none of these patients was lost to follow-up. During the study period, these patients experienced mild symptoms of shoulder pain and weakness, but none experienced recurrence of clinical symptoms, rotator cuff rerupture, or complications related to the human dermal allograft. Patients with severe glenohumeral arthritis and massive rotator cuff tears were not included in the current series because the authors consider severe glenohumeral arthritis a contraindication for rotator cuff repair; in such cases, they perform reverse total shoulder arthroplasty. Human dermal allograft has been previously used successfully for the reconstruction of irreparable rotator cuff tears. [19] [20] [21] [22] [23] [24] [25] Burkhead et al 25 reported significant improvement of function in a series of 17 patients who had open rotator cuff repair with side-to-side margin convergence sutures and augmentation with human dermal allograft. At a mean followup of 1.2 years, 11 patients reported no or occasional slight pain; 12 patients had normal or slight restriction of shoulder motion, with 10 patients having more than 150° active forward flexion. However, in that series, there was no rotator cuff defect; instead, the surgeons used human dermal allograft to augment the repair. 25 Bond et al 23 used human dermal allograft as a bridging material through an allarthroscopic technique to reconstruct massive rotator cuff tears with cuff defects. Their results showed significant improvement of function and high patient satisfaction without the morbidity of tendon transfer or total shoulder arthroplasty. 23 Porcine dermal and small intestine submucosa xenografts have also been used for rotator cuff repair; however, the reported results have been unfavorable. [15] [16] [17] [18] Badhe et al 18 reported significant improvement of ROM and function and intact repair at 4.5-year follow-up. However, other authors using collagen patches derived from porcine small intestine submucosa reported low healing potential with high failure rates and poor functional outcomes. 15 Soler et al 17 reported crosslinked porcine dermal xenograft used to reconstruct massive rotator cuff defects; however, all procedures failed within 3 to 6 months postoperatively, and the authors advised against the use of such grafts for massive rotator cuff reconstructions.
Variable operative techniques have also been reported for rotator cuff repair. The current authors perform arthroscopic debridement with or without subacromial decompression in elderly and lowdemand patients with pain but preserved preoperative active motion. They also perform partial repair of rotator cuff tears in patients with good tissue quality when an isolated repair of the infraspinatus or margin convergence rotator cuff repair can be performed safely. Tendon transfers have also shown favorable results for irreparable rotator cuff tears. [12] [13] [14] 45 However, the authors believe that patient selection is important for a tendon transfer. They believe that transfer of the latissimus dorsi tendon is a viable surgical option for young patients with at least 90° of arm elevation, patients who require shoulder strength to perform occupational tasks, and patients who are able and willing to participate in a long and rigorous rehabilitation program. The combination of acromioplasty, distal clavicle excision, and biceps tenotomy or tenodesis has a fundamental role in pain relief after massive rotator cuff repair. 29, 30, [41] [42] [43] The biceps tendon has a minimal role as a humeral head depressor; in addition, biceps pathology is known to be responsible for continued pain in patients with irreparable rotator cuff tears. [41] [42] [43] Therefore, the authors believe that there is no role for the biceps tendon to be retained in patients with rotator cuff repairs; instead, tenotomy or tenodesis of the tendon should be performed.
Human dermal allograft has shown excellent biocompatibility in soft tissue surgery such as Achilles tendon reconstruction, rotator cuff repair, and thumb carpometacarpal joint arthroplasty. [19] [20] [21] [22] [23] [24] [25] As in the current study, complications related to the allograft have not been reported. In contrast, aseptic inflammatory reaction and drainage have been reported after using collagen-based material derived from xenograft (porcine) dermal allograft. [15] [16] [17] [18] conclusion Human dermal allograft can be used successfully and safely for the reconstruction of massive rotator cuff tears as an interpositional graft when a palliative (debridement, nonanatomical repair) or a salvaging (tendon transfer) procedure is contraindicated. The size of the tendon gap is the most important predictor of postoperative pain, ROM, and function.
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